Team:TU Delft/6 July 2010 content
From 2010.igem.org
(→Lab work) |
(→Lab work) |
||
Line 69: | Line 69: | ||
|} | |} | ||
- | + | The digestion products were purified using Roche's PCR Purifiation Kit and loaded onto a 1% agarose gel for comparison with the non-digested BioBricks: | |
+ | |||
+ | [[Image:TUDelft_undigested-digested_06_July.png|500px|thumb|left|Digestion check]] | ||
+ | |||
+ | Lane description: | ||
+ | {|style="color:black; background-color:white;" cellpadding="5" cellspacing="0" border="1" | ||
+ | |'''#''' | ||
+ | |'''Description''' | ||
+ | |'''Expected Length (bp)''' | ||
+ | |'''Remarks''' | ||
+ | |- | ||
+ | |1 | ||
+ | |SmartLadder marker (5 μL) | ||
+ | |n/a | ||
+ | | | ||
+ | |- | ||
+ | |2 | ||
+ | |Undigested J61100 (1 μL + 4 μL MQ + 1 μL Loading Buffer) | ||
+ | | | ||
+ | |Circular Plasmid | ||
+ | |- | ||
+ | |3 | ||
+ | |Undigested J61101 (1 μL + 4 μL MQ + 1 μL Loading Buffer) | ||
+ | | | ||
+ | |Circular Plasmid | ||
+ | |- | ||
+ | |4 | ||
+ | |‘S – J61100 - pSB1A2 – P’ | ||
+ | |2116 | ||
+ | |Visible | ||
+ | |- | ||
+ | |5 | ||
+ | |‘S – J61101 - pSB1A2 – P’ | ||
+ | |2116 | ||
+ | |Visible | ||
+ | |- | ||
+ | |6 | ||
+ | |Undigested J61107 (1 μL + 4 μL MQ + 1 μL Loading Buffer) | ||
+ | | | ||
+ | |Circular plasmid | ||
+ | |- | ||
+ | |7 | ||
+ | |‘S – J61107 - pSB1A2 – P’ | ||
+ | |2116 | ||
+ | |Visible | ||
+ | |- | ||
+ | |8 | ||
+ | |Undigested J61117 (1 μL + 4 μL MQ + 1 μL Loading Buffer) | ||
+ | | | ||
+ | |Circular plasmid | ||
+ | |- | ||
+ | |9 | ||
+ | |‘S – J61117 - pSB1A2 – P’ | ||
+ | |2116 | ||
+ | |Visible | ||
+ | |- | ||
+ | |10 | ||
+ | |Undigested J61127 (1 μL + 4 μL MQ + 1 μL Loading Buffer) | ||
+ | | | ||
+ | |Circular plasmid | ||
+ | |- | ||
+ | |11 | ||
+ | |‘S – J61127 - pSB1A2 – P’ | ||
+ | |2116 | ||
+ | |Visible | ||
+ | |- | ||
+ | |12 | ||
+ | |Undigested I13401 (1 μL + 4 μL MQ + 1 μL Loading Buffer) | ||
+ | | | ||
+ | |Circular plasmid | ||
+ | |- | ||
+ | |13 | ||
+ | |‘X – I13401 – P’ | ||
+ | |883 | ||
+ | |Visible | ||
+ | |- | ||
+ | |14 | ||
+ | |empty | ||
+ | |empty | ||
+ | |empty | ||
+ | |- | ||
+ | |15 | ||
+ | |BioRad EZ Load | ||
+ | |n/a | ||
+ | |Visible | ||
+ | |} | ||
+ | |||
+ | Subsequent overnight [https://2010.igem.org/Team:TU_Delft/protocols/ligation ligation] yielded: | ||
{| style="color:black; background-color:white;" cellpadding="5" cellspacing="0" border="1" | {| style="color:black; background-color:white;" cellpadding="5" cellspacing="0" border="1" |
Revision as of 12:53, 20 July 2010
Contents |
Lab work
Ordered DNA stocks
The DNA from Mr Gene has finally arrived, now we're ready to build some biobricks!
We were so excited; we immediately dissolved the DNA in water and performed a transformation with 100 ng of the DNA and plated on the LB agar containing the appropriate antibiotic.
- AlkB2 (Ampicillin)
- rubA3 (Ampicillin)
- rubA4 (Ampicillin)
- rubB (Kanamycin)
- ladA (Ampicillin)
- ADH (Ampicillin)
- ALDH (Kanamycin)
- bbc1 (Ampicillin)
- AlnA (Ampicillin)
- OprG (Ampicillin)
- PalkS1-2 (Ampicillin)
- PalkB (Ampicillin)
- P(CaiF) (Ampenicillin)
- AlkS (Kanamycin)
- PhPFD-α (Ampicillin)
- PhPFD-β (Ampicillin)
Characterization of Anderson RBS sequences
Yesterday's purified PCR product of I13401 and the Anderson RBS Biobricks (J61100, J61101, J61107, J61117 and J61127) were digested:
# | Digestion reaction | Used Buffer | Needed fragment |
C1 | 1.15 μg J61100 + SpeI + PstI | Buffer 2 (BioLabs) | ‘S – J61100 - pSB1A2 – P’ |
C2 | 1.68 μg J61101 + SpeI + PstI | Buffer 2 (BioLabs) | ‘S – J61101 - pSB1A2 – P’ |
C3 | 1.30 μg J61107 + SpeI + PstI | Buffer 2 (BioLabs) | ‘S – J61107 - pSB1A2 – P’ |
C4 | 0.95 μg J61117 + SpeI + PstI | Buffer 2 (BioLabs) | ‘S – J61117 - pSB1A2 – P’ |
C5 | 0.51 μg J61127 + SpeI + PstI | Buffer 2 (BioLabs) | ‘S – J61127 - pSB1A2 – P’ |
D1 | 2.59 μg I13401 + XbaI + PstI | Buffer 2 (BioLabs) | ‘X – I13401 – P’ |
D2 | 2.65 μg I13401 + XbaI + PstI | Buffer 2 (BioLabs) | ‘X – I13401 – P’ |
The digestion products were purified using Roche's PCR Purifiation Kit and loaded onto a 1% agarose gel for comparison with the non-digested BioBricks:
Lane description:
# | Description | Expected Length (bp) | Remarks |
1 | SmartLadder marker (5 μL) | n/a | |
2 | Undigested J61100 (1 μL + 4 μL MQ + 1 μL Loading Buffer) | Circular Plasmid | |
3 | Undigested J61101 (1 μL + 4 μL MQ + 1 μL Loading Buffer) | Circular Plasmid | |
4 | ‘S – J61100 - pSB1A2 – P’ | 2116 | Visible |
5 | ‘S – J61101 - pSB1A2 – P’ | 2116 | Visible |
6 | Undigested J61107 (1 μL + 4 μL MQ + 1 μL Loading Buffer) | Circular plasmid | |
7 | ‘S – J61107 - pSB1A2 – P’ | 2116 | Visible |
8 | Undigested J61117 (1 μL + 4 μL MQ + 1 μL Loading Buffer) | Circular plasmid | |
9 | ‘S – J61117 - pSB1A2 – P’ | 2116 | Visible |
10 | Undigested J61127 (1 μL + 4 μL MQ + 1 μL Loading Buffer) | Circular plasmid | |
11 | ‘S – J61127 - pSB1A2 – P’ | 2116 | Visible |
12 | Undigested I13401 (1 μL + 4 μL MQ + 1 μL Loading Buffer) | Circular plasmid | |
13 | ‘X – I13401 – P’ | 883 | Visible |
14 | empty | empty | empty |
15 | BioRad EZ Load | n/a | Visible |
Subsequent overnight ligation yielded:
# | Ligation reaction |
1 | 3 μL I10341 + 4 μL J1100 + 1.5 μL pSB1C3 |
2 | 3 μL I10341 + 4 μL J1101 + 1.5 μL pSB1C3 |
3 | 3 μL I10341 + 4 μL J1107 + 1.5 μL pSB1C3 |
4 | 3 μL I10341 + 4 μL J1117 + 1.5 μL pSB1C3 |
5 | 3 μL I10341 + 4 μL J1127 + 1.5 μL pSB1C3 |
6 | 4 μL J1100 + 1.5 μL pSB3C5 (negative control) |
Emulsifier
Pieter is testing different condition for the emulsifying Assay. To determine the emulsifying activity we set up a calibration curve with SDS. He prepared the following samples:
# | Hexane (mL) | Tris Buffer pH 8 (mL) | 10% SDS (mL) |
B | 1 | 1.1 | 0 |
100 | 1 | 1 | 0.1 |
50 | 1 | 1.05 | 0.05 |
25 | 1 | 1.075 | 0.025 |
10 | 1 | 1.09 | 0.01 |
5 | 1 | 1.095 | 0.005 |
Kampioenen!!!!
Today the Dutch team will play the semi-final of the World Cup! Hear us cheer! Stop sound